TIDMGSK

RNS Number : 9616P

GlaxoSmithKline PLC

15 October 2019

GlaxoSmithKline plc (the 'Company')

Transaction notification

 
 1.   Details of PDMR/person closely associated with them ('PCA') 
     ====================================================================== 
 a)   Name                      Ms E Walmsley 
===  =========================  =========================================== 
 b)   Position/status           Chief Executive Officer 
===  =========================  =========================================== 
 c)   Initial notification/     Initial notification 
       amendment 
===  =========================  =========================================== 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ====================================================================== 
 a)   Name                      GlaxoSmithKline plc 
===  =========================  =========================================== 
 b)   LEI                       5493000HZTVUYLO1D793 
===  =========================  =========================================== 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ====================================================================== 
 a)   Description of            Ordinary shares of 25 pence each ('Ordinary 
       the financial             Shares') 
       instrument                ISIN: GB0009252882 
===  =========================  =========================================== 
 b)   Nature of the             Acquisition of Ordinary Shares following 
       transaction               the re-investment of dividends paid to 
                                 shareholders on 10 October 2019. 
===  =========================  =========================================== 
 c)   Price(s) and volume(s)      Price(s)       Volume(s) 
                                                 ---------- 
                                   GBP 16.6032    1469.682 
                                                 ---------- 
===  =========================  =========================================== 
 d)   Aggregated information    N/A (single transaction) 
       Aggregated volume 
       Price 
===  =========================  =========================================== 
 e)   Date of the transaction   2019-10-11 
===  =========================  =========================================== 
 f)   Place of the transaction  London Stock Exchange (XLON) 
===  =========================  =========================================== 
 
 
 1.   Details of PDMR/person closely associated with them ('PCA') 
     ====================================================================== 
 a)   Name                      Mr R Connor 
===  =========================  =========================================== 
 b)   Position/status           President, Global Vaccines 
===  =========================  =========================================== 
 c)   Initial notification/     Initial notification 
       amendment 
===  =========================  =========================================== 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ====================================================================== 
 a)   Name                      GlaxoSmithKline plc 
===  =========================  =========================================== 
 b)   LEI                       5493000HZTVUYLO1D793 
===  =========================  =========================================== 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ====================================================================== 
 a)   Description of            Ordinary shares of 25 pence each ('Ordinary 
       the financial             Shares') 
       instrument                ISIN: GB0009252882 
===  =========================  =========================================== 
 b)   Nature of the             Acquisition of Ordinary Shares following 
       transaction               the re-investment of dividends paid to 
                                 shareholders on 10 October 2019. 
===  =========================  =========================================== 
 c)   Price(s) and volume(s)      Price(s)       Volume(s) 
                                                 ---------- 
                                   GBP 16.6032    661.719 
                                                 ---------- 
===  =========================  =========================================== 
 d)   Aggregated information    N/A (single transaction) 
       Aggregated volume 
       Price 
===  =========================  =========================================== 
 e)   Date of the transaction   2019-10-11 
===  =========================  =========================================== 
 f)   Place of the transaction  London Stock Exchange (XLON) 
===  =========================  =========================================== 
 
 
 1.   Details of PDMR/person closely associated with them ('PCA') 
     ====================================================================== 
 a)   Name                      Ms D Conrad 
===  =========================  =========================================== 
 b)   Position/status           SVP, Human Resources 
===  =========================  =========================================== 
 c)   Initial notification/     Initial notification 
       amendment 
===  =========================  =========================================== 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ====================================================================== 
 a)   Name                      GlaxoSmithKline plc 
===  =========================  =========================================== 
 b)   LEI                       5493000HZTVUYLO1D793 
===  =========================  =========================================== 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ====================================================================== 
 a)   Description of            Ordinary shares of 25 pence each ('Ordinary 
       the financial             Shares') 
       instrument                ISIN: GB0009252882 
===  =========================  =========================================== 
 b)   Nature of the             Acquisition of Ordinary Shares following 
       transaction               the re-investment of dividends paid to 
                                 shareholders on 10 October 2019. 
===  =========================  =========================================== 
 c)   Price(s) and volume(s)      Price(s)       Volume(s) 
                                                 ---------- 
                                   GBP 16.6032    7.181 
                                                 ---------- 
===  =========================  =========================================== 
 d)   Aggregated information    N/A (single transaction) 
       Aggregated volume 
       Price 
===  =========================  =========================================== 
 e)   Date of the transaction   2019-10-11 
===  =========================  =========================================== 
 f)   Place of the transaction  London Stock Exchange (XLON) 
===  =========================  =========================================== 
 
 
 1.   Details of PDMR/person closely associated with them ('PCA') 
     ====================================================================== 
 a)   Name                      Mr J Ford 
===  =========================  =========================================== 
 b)   Position/status           SVP & General Counsel 
===  =========================  =========================================== 
 c)   Initial notification/     Initial notification 
       amendment 
===  =========================  =========================================== 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ====================================================================== 
 a)   Name                      GlaxoSmithKline plc 
===  =========================  =========================================== 
 b)   LEI                       5493000HZTVUYLO1D793 
===  =========================  =========================================== 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ====================================================================== 
 a)   Description of            Ordinary shares of 25 pence each ('Ordinary 
       the financial             Shares') 
       instrument                ISIN: GB0009252882 
===  =========================  =========================================== 
 b)   Nature of the             Acquisition of Ordinary Shares following 
       transaction               the re-investment of dividends paid to 
                                 shareholders on 10 October 2019. 
===  =========================  =========================================== 
 c)   Price(s) and volume(s)      Price(s)       Volume(s) 
                                                 ---------- 
                                   GBP 16.6032    0.000026 
                                                 ---------- 
===  =========================  =========================================== 
 d)   Aggregated information    N/A (single transaction) 
       Aggregated volume 
       Price 
===  =========================  =========================================== 
 e)   Date of the transaction   2019-10-11 
===  =========================  =========================================== 
 f)   Place of the transaction  London Stock Exchange (XLON) 
===  =========================  =========================================== 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ========================================================================== 
 a)   Name                      Mr J Ford 
===  =========================  =============================================== 
 b)   Position/status           SVP & General Counsel 
===  =========================  =============================================== 
 c)   Initial notification/     Initial notification 
       amendment 
===  =========================  =============================================== 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ========================================================================== 
 a)   Name                      GlaxoSmithKline plc 
===  =========================  =============================================== 
 b)   LEI                       5493000HZTVUYLO1D793 
===  =========================  =============================================== 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ========================================================================== 
 a)   Description of            American Depositary Shares ('ADSs') 
       the financial             ISIN: US37733W1053 
       instrument 
===  =========================  =============================================== 
 b)   Nature of the             Acquisition of ADSs following the re-investment 
       transaction               of dividends paid to shareholders on 10 
                                 October 2019. 
===  =========================  =============================================== 
 c)   Price(s) and volume(s)      Price(s)    Volume(s) 
                                              ---------- 
                                   $ 42.2439   0.001 
                                              ---------- 
===  =========================  =============================================== 
 d)   Aggregated information    N/A (single transaction) 
       Aggregated volume 
       Price 
===  =========================  =============================================== 
 e)   Date of the transaction   2019-10-11 
===  =========================  =============================================== 
 f)   Place of the transaction  New York Stock Exchange (XNYS) 
===  =========================  =============================================== 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ====================================================================== 
 a)   Name                      Mr N Hirons 
===  =========================  =========================================== 
 b)   Position/status           SVP, Global Ethics & Compliance 
===  =========================  =========================================== 
 c)   Initial notification/     Initial notification 
       amendment 
===  =========================  =========================================== 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ====================================================================== 
 a)   Name                      GlaxoSmithKline plc 
===  =========================  =========================================== 
 b)   LEI                       5493000HZTVUYLO1D793 
===  =========================  =========================================== 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ====================================================================== 
 a)   Description of            Ordinary shares of 25 pence each ('Ordinary 
       the financial             Shares') 
       instrument                ISIN: GB0009252882 
===  =========================  =========================================== 
 b)   Nature of the             Acquisition of Ordinary Shares following 
       transaction               the re-investment of dividends paid to 
                                 shareholders on 10 October 2019. 
===  =========================  =========================================== 
 c)   Price(s) and volume(s)      Price(s)       Volume(s) 
                                                 ---------- 
                                   GBP 16.6032    407.873 
                                                 ---------- 
===  =========================  =========================================== 
 d)   Aggregated information    N/A (single transaction) 
       Aggregated volume 
       Price 
===  =========================  =========================================== 
 e)   Date of the transaction   2019-10-11 
===  =========================  =========================================== 
 f)   Place of the transaction  London Stock Exchange (XLON) 
===  =========================  =========================================== 
 
 
 1.   Details of PDMR/person closely associated with them ('PCA') 
     ========================================================================== 
 a)   Name                      Mr N Hirons 
===  =========================  =============================================== 
 b)   Position/status           SVP, Global Ethics & Compliance 
===  =========================  =============================================== 
 c)   Initial notification/     Initial notification 
       amendment 
===  =========================  =============================================== 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ========================================================================== 
 a)   Name                      GlaxoSmithKline plc 
===  =========================  =============================================== 
 b)   LEI                       5493000HZTVUYLO1D793 
===  =========================  =============================================== 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ========================================================================== 
 a)   Description of             American Depositary Shares ('ADSs') 
       the financial              ISIN: US37733W1053 
       instrument 
===  =========================  =============================================== 
 b)   Nature of the             Acquisition of ADSs following the re-investment 
       transaction               of dividends paid to shareholders on 10 
                                 October 2019. 
===  =========================  =============================================== 
 c)   Price(s) and volume(s)      Price(s)    Volume(s) 
                                              ---------- 
                                   $ 42.2439   17.449 
                                              ---------- 
===  =========================  =============================================== 
 d)   Aggregated information    N/A (single transaction) 
       Aggregated volume 
       Price 
===  =========================  =============================================== 
 e)   Date of the transaction   2019-10-11 
===  =========================  =============================================== 
 f)   Place of the transaction  New York Stock Exchange (XNYS) 
===  =========================  =============================================== 
 
 
 1.   Details of PDMR/person closely associated with them ('PCA') 
     ========================================================================== 
 a)   Name                      Mr D Jackson 
===  =========================  =============================================== 
 b)   Position/status           PCA of Ms S Jackson (SVP, Global Communications 
                                 and CEO Office) 
===  =========================  =============================================== 
 c)   Initial notification/     Initial notification 
       amendment 
===  =========================  =============================================== 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ========================================================================== 
 a)   Name                      GlaxoSmithKline plc 
===  =========================  =============================================== 
 b)   LEI                       5493000HZTVUYLO1D793 
===  =========================  =============================================== 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ========================================================================== 
 a)   Description of            Ordinary shares of 25 pence each ('Ordinary 
       the financial             Shares') 
       instrument                ISIN: GB0009252882 
===  =========================  =============================================== 
 b)   Nature of the             Acquisition of Ordinary Shares following 
       transaction               the re-investment of dividends paid to 
                                 shareholders on 10 October 2019. 
===  =========================  =============================================== 
 c)   Price(s) and volume(s)      Price(s)       Volume(s) 
                                                 ---------- 
                                   GBP 16.6032    58.431 
                                                 ---------- 
===  =========================  =============================================== 
 d)   Aggregated information    N/A (single transaction) 
       Aggregated volume 
       Price 
===  =========================  =============================================== 
 e)   Date of the transaction   2019-10-11 
===  =========================  =============================================== 
 f)   Place of the transaction  London Stock Exchange (XLON) 
===  =========================  =============================================== 
 
 
 1.   Details of PDMR/person closely associated with them ('PCA') 
     ====================================================================== 
 a)   Name                      Ms S Jackson 
===  =========================  =========================================== 
 b)   Position/status           SVP, Global Communications and CEO Office 
===  =========================  =========================================== 
 c)   Initial notification/     Initial notification 
       amendment 
===  =========================  =========================================== 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ====================================================================== 
 a)   Name                      GlaxoSmithKline plc 
===  =========================  =========================================== 
 b)   LEI                       5493000HZTVUYLO1D793 
===  =========================  =========================================== 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ====================================================================== 
 a)   Description of            Ordinary shares of 25 pence each ('Ordinary 
       the financial             Shares') 
       instrument                ISIN: GB0009252882 
===  =========================  =========================================== 
 b)   Nature of the             Acquisition of Ordinary Shares following 
       transaction               the re-investment of dividends paid to 
                                 shareholders on 10 October 2019. 
===  =========================  =========================================== 
 c)   Price(s) and volume(s)      Price(s)       Volume(s) 
                                                 ---------- 
                                   GBP 16.6032    89.074 
                                                 ---------- 
===  =========================  =========================================== 
 d)   Aggregated information    N/A (single transaction) 
       Aggregated volume 
       Price 
===  =========================  =========================================== 
 e)   Date of the transaction   2019-10-11 
===  =========================  =========================================== 
 f)   Place of the transaction  London Stock Exchange (XLON) 
===  =========================  =========================================== 
 
 
 1.   Details of PDMR/person closely associated with them ('PCA') 
     ========================================================================== 
 a)   Name                      Mr B McNamara 
===  =========================  =============================================== 
 b)   Position/status           CEO, GSK Consumer Healthcare 
===  =========================  =============================================== 
 c)   Initial notification/     Initial notification 
       amendment 
===  =========================  =============================================== 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ========================================================================== 
 a)   Name                      GlaxoSmithKline plc 
===  =========================  =============================================== 
 b)   LEI                       5493000HZTVUYLO1D793 
===  =========================  =============================================== 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ========================================================================== 
 a)   Description of             American Depositary Shares ('ADSs') 
       the financial              ISIN: US37733W1053 
       instrument 
===  =========================  =============================================== 
 b)   Nature of the             Acquisition of ADSs following the re-investment 
       transaction               of dividends paid to shareholders on 10 
                                 October 2019. 
===  =========================  =============================================== 
 c)   Price(s) and volume(s)      Price(s)    Volume(s) 
                                              ---------- 
                                   $ 42.2439   673.667 
                                              ---------- 
===  =========================  =============================================== 
 d)   Aggregated information    N/A (single transaction) 
       Aggregated volume 
       Price 
===  =========================  =============================================== 
 e)   Date of the transaction   2019-10-11 
===  =========================  =============================================== 
 f)   Place of the transaction  New York Stock Exchange (XNYS) 
===  =========================  =============================================== 
 
 
 1.   Details of PDMR/person closely associated with them ('PCA') 
     ====================================================================== 
 a)   Name                      Mr D Redfern 
===  =========================  =========================================== 
 b)   Position/status           Chief Strategy Officer 
===  =========================  =========================================== 
 c)   Initial notification/     Initial notification 
       amendment 
===  =========================  =========================================== 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ====================================================================== 
 a)   Name                      GlaxoSmithKline plc 
===  =========================  =========================================== 
 b)   LEI                       5493000HZTVUYLO1D793 
===  =========================  =========================================== 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ====================================================================== 
 a)   Description of            Ordinary shares of 25 pence each ('Ordinary 
       the financial             Shares') 
       instrument                ISIN: GB0009252882 
===  =========================  =========================================== 
 b)   Nature of the             Acquisition of Ordinary Shares following 
       transaction               the re-investment of dividends paid to 
                                 shareholders on 10 October 2019. 
===  =========================  =========================================== 
 c)   Price(s) and volume(s)      Price(s)       Volume(s) 
                                                 ---------- 
                                   GBP 16.6032    2433.133 
                                                 ---------- 
===  =========================  =========================================== 
 d)   Aggregated information    N/A (single transaction) 
       Aggregated volume 
       Price 
===  =========================  =========================================== 
 e)   Date of the transaction   2019-10-11 
===  =========================  =========================================== 
 f)   Place of the transaction  London Stock Exchange (XLON) 
===  =========================  =========================================== 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
     ====================================================================== 
 a)   Name                      Mr R Simard 
===  =========================  =========================================== 
 b)   Position/status           President, Pharmaceuticals Supply Chain 
===  =========================  =========================================== 
 c)   Initial notification/     Initial notification 
       amendment 
===  =========================  =========================================== 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ====================================================================== 
 a)   Name                      GlaxoSmithKline plc 
===  =========================  =========================================== 
 b)   LEI                       5493000HZTVUYLO1D793 
===  =========================  =========================================== 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ====================================================================== 
 a)   Description of            Ordinary shares of 25 pence each ('Ordinary 
       the financial             Shares') 
       instrument                ISIN: GB0009252882 
===  =========================  =========================================== 
 b)   Nature of the             Acquisition of Ordinary Shares following 
       transaction               the re-investment of dividends paid to 
                                 shareholders on 10 October 2019. 
===  =========================  =========================================== 
 c)   Price(s) and volume(s)      Price(s)       Volume(s) 
                                                 ---------- 
                                   GBP 16.6032    467.749 
                                                 ---------- 
===  =========================  =========================================== 
 d)   Aggregated information    N/A (single transaction) 
       Aggregated volume 
       Price 
===  =========================  =========================================== 
 e)   Date of the transaction   2019-10-11 
===  =========================  =========================================== 
 f)   Place of the transaction  London Stock Exchange (XLON) 
===  =========================  =========================================== 
 
 
 1.   Details of PDMR/person closely associated with them ('PCA') 
     ====================================================================== 
 a)   Name                      Ms K Thomson 
===  =========================  =========================================== 
 b)   Position/status           PCA of Mr P Thomson (President, Global 
                                 Affairs) 
===  =========================  =========================================== 
 c)   Initial notification/     Initial notification 
       amendment 
===  =========================  =========================================== 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ====================================================================== 
 a)   Name                      GlaxoSmithKline plc 
===  =========================  =========================================== 
 b)   LEI                       5493000HZTVUYLO1D793 
===  =========================  =========================================== 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ====================================================================== 
 a)   Description of            Ordinary shares of 25 pence each ('Ordinary 
       the financial             Shares') 
       instrument                ISIN: GB0009252882 
===  =========================  =========================================== 
 b)   Nature of the             Acquisition of Ordinary Shares following 
       transaction               the re-investment of dividends paid to 
                                 shareholders on 10 October 2019. 
===  =========================  =========================================== 
 c)   Price(s) and volume(s)      Price(s)       Volume(s) 
                                                 ---------- 
                                   GBP 16.6032    121.975 
                                                 ---------- 
===  =========================  =========================================== 
 d)   Aggregated information    N/A (single transaction) 
       Aggregated volume 
       Price 
===  =========================  =========================================== 
 e)   Date of the transaction   2019-10-11 
===  =========================  =========================================== 
 f)   Place of the transaction  London Stock Exchange (XLON) 
===  =========================  =========================================== 
 
 
 1.   Details of PDMR/person closely associated with them ('PCA') 
     ====================================================================== 
 a)   Name                      Mr P Thomson 
===  =========================  =========================================== 
 b)   Position/status           President, Global Affairs 
===  =========================  =========================================== 
 c)   Initial notification/     Initial notification 
       amendment 
===  =========================  =========================================== 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ====================================================================== 
 a)   Name                      GlaxoSmithKline plc 
===  =========================  =========================================== 
 b)   LEI                       5493000HZTVUYLO1D793 
===  =========================  =========================================== 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ====================================================================== 
 a)   Description of            Ordinary shares of 25 pence each ('Ordinary 
       the financial             Shares') 
       instrument                ISIN: GB0009252882 
===  =========================  =========================================== 
 b)   Nature of the             Acquisition of Ordinary Shares following 
       transaction               the re-investment of dividends paid to 
                                 shareholders on 10 October 2019. 
===  =========================  =========================================== 
 c)   Price(s) and volume(s)      Price(s)       Volume(s) 
                                                 ---------- 
                                   GBP 16.6032    559.520 
                                                 ---------- 
===  =========================  =========================================== 
 d)   Aggregated information    N/A (single transaction) 
       Aggregated volume 
       Price 
===  =========================  =========================================== 
 e)   Date of the transaction   2019-10-11 
===  =========================  =========================================== 
 f)   Place of the transaction  London Stock Exchange (XLON) 
===  =========================  =========================================== 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHLELFFKBFZFBB

(END) Dow Jones Newswires

October 15, 2019 12:00 ET (16:00 GMT)

Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Feb 2024 a Mar 2024 Haga Click aquí para más Gráficas Gsk.
Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Mar 2023 a Mar 2024 Haga Click aquí para más Gráficas Gsk.